HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob Disease.

Abstract
A high priority in the prion field is to identify pre-symptomatic events and associated profile of molecular changes. In this study, we demonstrate the pre-symptomatic dysregulation of cytoskeleton assembly and its associated cofilin-1 pathway in strain and brain region-specific manners in MM1 and VV2 subtype-specific Creutzfeldt-Jakob disease at clinical and pre-clinical stage. At physiological level, PrPC interaction with cofilin-1 and phosphorylated form of cofilin (p-cofilin(Ser3)) was investigated in primary cultures of mouse cortex neurons (PCNs) of PrPC wild-type and knockout mice (PrP-/-). Short-interfering RNA downregulation of active form of cofilin-1 resulted in the redistribution/downregulation of PrPC, increase of activated form of microglia, accumulation of dense form of F-actin, and upregulation of p-cofilin(Ser3). This upregulated p-cofilin(Ser3) showed redistribution of expression predominantly in the activated form of microglia in PCNs. At pathological level, cofilin-1 expression was significantly altered in cortex and cerebellum in both humans and mice at pre-clinical stage and at early symptomatic clinical stage of the disease. Further, to better understand the possible mechanism of dysregulation of cofilin-1, we also demonstrated alterations in upstream regulators; LIM kinase isoform 1 (LIMK1), slingshot phosphatase isoform 1 (SSH1), RhoA-associated kinase (Rock2), and amyloid precursor protein (APP) in sporadic Creutzfeldt-Jakob disease MM1 mice and in human MM1 and VV2 frontal cortex and cerebellum samples. In conclusion, our findings demonstrated for the first time a key pre-clinical response of cofilin-1 and the associated pathway in prion disease.
AuthorsSaima Zafar, Neelam Younas, Nadeem Sheikh, Waqas Tahir, Mohsin Shafiq, Matthias Schmitz, Isidre Ferrer, Olivier Andréoletti, Inga Zerr
JournalMolecular neurobiology (Mol Neurobiol) Vol. 55 Issue 5 Pg. 4009-4029 (May 2018) ISSN: 1559-1182 [Electronic] United States
PMID28573459 (Publication Type: Journal Article)
Chemical References
  • Actins
  • Aif1 protein, mouse
  • Amyloid beta-Peptides
  • Calcium-Binding Proteins
  • Cofilin 1
  • Microfilament Proteins
  • PrPC Proteins
  • RNA, Small Interfering
  • LIMK1 protein, human
  • Lim Kinases
  • ROCK2 protein, human
  • rho-Associated Kinases
  • Calcineurin
  • Phosphoprotein Phosphatases
  • SSH1 protein, human
Topics
  • Actins (metabolism)
  • Aged
  • Amyloid beta-Peptides (metabolism)
  • Animals
  • Calcineurin (metabolism)
  • Calcium-Binding Proteins (metabolism)
  • Cell Survival
  • Cells, Cultured
  • Cofilin 1 (metabolism)
  • Creutzfeldt-Jakob Syndrome (pathology)
  • Cytoskeleton (metabolism)
  • Disease Progression
  • Female
  • Gene Silencing
  • Humans
  • Lim Kinases (metabolism)
  • Male
  • Mice, Transgenic
  • Microfilament Proteins (metabolism)
  • Microglia (metabolism)
  • Middle Aged
  • Neurons (metabolism)
  • Phosphoprotein Phosphatases (metabolism)
  • Phosphorylation
  • PrPC Proteins (metabolism)
  • Protein Binding
  • RNA, Small Interfering (metabolism)
  • Risk Factors
  • rho-Associated Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: